KC
ORIAW

Kepos Capital’s Orion Biotech Opportunities Corp. Warrant ORIAW Stock Holding History

Kepos Capital’s Portfolio ORIAW Stock Details ORIAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$12K Hold
80,000
– – ﹤0.01% 352
2022
Q3 		$14K Sell
80,000
-20,000
-20% -$4.33K ﹤0.01% 394
2022
Q2 		$15K Hold
100,000
– – ﹤0.01% 454
2022
Q1 		$37K Hold
100,000
– – ﹤0.01% 553
2021
Q4 		$96K Buy
+100,000
New +$104K 0.01% 517

Other funds holding ORIAW

RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.32B AUM 1.82% 1-Year Est. Return
AGC
Angelo Gordon & Co New York $1.06B AUM 47.95% 1-Year Est. Return
SCM
Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $1.14B AUM 6.91% 1-Year Est. Return
GAM
Gritstone Asset Management Bethesda, Maryland $104M AUM 6.03% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
KL
KIM LLC Wichita, Kansas $1B AUM 29.68% 1-Year Est. Return
LA
Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return

Kepos Capital's ORIAW Position: Q4 2022 in Review

Kepos Capital held its Orion Biotech Opportunities Corp. Warrant (ORIAW) position steady in Q4 2022 at 80,000 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #352.

Kepos Capital first reported a position in ORIAW in Q4 2021 and has held it in 5 quarters since. The position peaked at $96K in Q4 2021. 29 funds tracked by Wall St. Rank hold ORIAW as of Q4 2022.

  • Kepos Capital held 80,000 shares of Orion Biotech Opportunities Corp. Warrant worth $12K as of Q4 2022.
  • Kepos Capital left its Orion Biotech Opportunities Corp. Warrant share count unchanged in Q4 2022.
  • Orion Biotech Opportunities Corp. Warrant made up ﹤0.01% of Kepos Capital's portfolio in Q4 2022, its #352 holding.
  • Kepos Capital first reported a position in Orion Biotech Opportunities Corp. Warrant in Q4 2021 and has held it in 5 quarters since.
  • Kepos Capital's Orion Biotech Opportunities Corp. Warrant position peaked at $96K in Q4 2021.
  • 29 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Warrant as of Q4 2022.

Based on Kepos Capital's 13F filing for Q4 2022, filed 13 Feb 2023.